Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3068)
All Articles published online
|
Feb 15, 2003 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wu BW, Wu Y, Wang JL, Lin JS, Yuan SY, Li A, Cui WR. Study on the mechanism of epidermal growth factor-induced proliferation of hepatoma cells. World J Gastroenterol 2003; 9(2): 271-275 [PMID: 12532446 DOI: 10.3748/wjg.v9.i2.271] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i2/271.htm |
| Number | Citing Articles |
| 1 |
Shao-Ping Liu, Wei-Guo Dong, Dong-Fang Wu, He-Sheng Luo, Jie-Ping Yu. Protective effect of <italic>angelica sinensis</italic> polysaccharide on experimental immunological colon injury in rats. World Journal of Gastroenterology 2003; 9(12): 2786-2790 doi: 10.3748/wjg.v9.i12.2786
|
| 2 |
Bu-Dong Zhu, Shou-Jun Yuan, Qi-Cheng Zhao, Xin Li, Yan Li, Qi-Ying Lu. Antitumor effect of Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with cytotoxic agent on murine hepatocellular carcinoma. World Journal of Gastroenterology 2005; 11(9): 1382-1386 doi: 10.3748/wjg.v11.i9.1382
|
| 3 |
Hongbing Li, Marı́a José Ruano, Antonio Villalobo. Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. FEBS Letters 2004; 559(1-3): 175 doi: 10.1016/S0014-5793(04)00067-5
|
| 4 |
Dianshuai Huang, Qingjie Fan, Zhiyi Liu, Shuqin Zhang, Wei Huang, Hongrui Li, Chongyang Liang, Fei Sun. An Epitope on EGFR Loading Catastrophic Internalization Serve as a Novel Oncotarget for Hepatocellular Carcinoma Therapy. Cancers 2020; 12(2): 456 doi: 10.3390/cancers12020456
|
| 5 |
Christian Stock. Transportome Malfunction in the Cancer Spectrum. Reviews of Physiology, Biochemistry and Pharmacology 2020; 181: 129 doi: 10.1007/112_2020_41
|
| 6 |
Alexander Huether, Michael Höpfner, Viola Baradari, Detlef Schuppan, Hans Scherübl. EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer. Biochemical Pharmacology 2005; 70(11): 1568 doi: 10.1016/j.bcp.2005.09.007
|
| 7 |
Hongbing LI, Juan SÁNCHEZ-TORRES, Alan del CARPIO, Valentina SALAS, Antonio VILLALOBO. The ErbB2/Neu/HER2 receptor is a new calmodulin-binding protein. Biochemical Journal 2004; 381(1): 257 doi: 10.1042/BJ20040515
|
| 8 |
David Semela, Jean-François Dufour. Angiogenesis and hepatocellular carcinoma. Journal of Hepatology 2004; 41(5): 864 doi: 10.1016/j.jhep.2004.09.006
|
| 9 |
Pablo Sánchez‐González, Karim Jellali, Antonio Villalobo. Calmodulin‐mediated regulation of the epidermal growth factor receptor. The FEBS Journal 2010; 277(2): 327 doi: 10.1111/j.1742-4658.2009.07469.x
|
| 10 |
Juan Alcalde, María González-Muñoz, Antonio Villalobo. Grb7-derived calmodulin-binding peptides inhibit proliferation, migration and invasiveness of tumor cells while they enhance attachment to the substrate. Heliyon 2020; 6(5): e03922 doi: 10.1016/j.heliyon.2020.e03922
|
| 11 |
Caecilia HC Sukowati, Natalia Rosso, Lory S Crocè, Claudio Tiribelli. Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma. World Journal of Hepatology 2010; 2(3): 114-126 doi: 10.4254/wjh.v2.i3.114
|
| 12 |
Zhi-Su Liu, Sheng-Li Tang, Zhong-Li Ai. Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells. World Journal of Gastroenterology 2003; 9(9): 1968-1971 doi: 10.3748/wjg.v9.i9.1968
|
| 13 |
Jing Geng, Xinying Li, Xiaoling Lang, Chunxia Qiao, Meiyun Hu, Jing Yang, Jiannan Feng, Ming Lv. Combination of Cetuximab and Rapamycin Enhances the Therapeutic Efficacy in Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2014; 13(4): 377 doi: 10.7785/tcrt.2012.500389
|
| 14 |
Jian-Sheng Wang, Jing-Sen Shi, Yi-Zhuang Xu, Xiao-Yi Duan, Li Zhang, Jing Wang, Li-Ming Yang, Shi-Fu Weng, Jin-Guang Wu. FT-IR spectroscopic analysis of normal and cancerous tissues of esophagus. World Journal of Gastroenterology 2003; 9(9): 1897-1899 doi: 10.3748/wjg.v9.i9.1897
|
| 15 |
Bai-Jun Fang, Mei-Li Yu, Shao-Guang Yang, Lian-Ming Liao, Jie-Wen Liu, Robert -C-H Zhao. Effect of O-4-ethoxyl-butyl-berbamine in combination with pegylated liposomal doxorubicin on advanced hepatoma in mice. World Journal of Gastroenterology 2004; 10(7): 950-953 doi: 10.3748/wjg.v10.i7.950
|
| 16 |
Christopher D. Mann, Christopher P. Neal, Giuseppe Garcea, Margaret M. Manson, Ashley R. Dennison, David P. Berry. Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. European Journal of Cancer Prevention 2009; 18(1): 13 doi: 10.1097/CEJ.0b013e3282f0c090
|
| 17 |
Alexander Huether, Michael Höpfner, Andreas P. Sutter, Detlef Schuppan, Hans Scherübl. Erlotinib induces cell cycle arrest and apoptosis in hepatocellular cancer cells and enhances chemosensitivity towards cytostatics. Journal of Hepatology 2005; 43(4): 661 doi: 10.1016/j.jhep.2005.02.040
|
| 18 |
Rangaswamy Govindarajan, Eric Siegel, Issam Makhoul, Stephen Williamson. Bevacizumab and Erlotinib in Previously Untreated Inoperable and Metastatic Hepatocellular Carcinoma. American Journal of Clinical Oncology 2013; 36(3): 254 doi: 10.1097/COC.0b013e318248d83f
|
| 19 |
S. Chandradas, C.B. Skillin, C.T. Frenette. Introduction to Cancer Metastasis. 2017; : 163 doi: 10.1016/B978-0-12-804003-4.00009-8
|